Choueiri TK - Search Results

1

Sunitinib in renal-cell carcinoma: expanded indications.

Choueiri TK, Bellmunt J. Choueiri TK, et al. Lancet Oncol. 2009 Aug;10(8):740. doi: 10.1016/S1470-2045(09)70185-8. Epub 2009 Jul 15. Lancet Oncol. 2009. PMID: 19615941 Review. No abstract available.

2

Recent progress and pitfalls in testing novel agents in castration-resistant prostate cancer.

Bellmunt J, Rosenberg JE, Choueiri TK. Bellmunt J, et al. Among authors: choueiri tk. Eur Urol. 2009 Oct;56(4):606-8. doi: 10.1016/j.eururo.2009.07.015. Epub 2009 Jul 22. Eur Urol. 2009. PMID: 19635642 No abstract available.

3

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials.

Je Y, Schutz FA, Choueiri TK. Je Y, et al. Among authors: choueiri tk. Lancet Oncol. 2009 Oct;10(10):967-74. doi: 10.1016/S1470-2045(09)70222-0. Epub 2009 Sep 18. Lancet Oncol. 2009. PMID: 19767240 Review.

4

Targeted therapies: sunitinib in RCC-expanded access equals expanded benefit?

Choueiri TK, Atkins MB. Choueiri TK, et al. Nat Rev Clin Oncol. 2009 Dec;6(12):679-80. doi: 10.1038/nrclinonc.2009.170. Nat Rev Clin Oncol. 2009. PMID: 19942921

5

Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens.

Bellmunt J, Choueiri TK, Fougeray R, Schutz FA, Salhi Y, Winquist E, Culine S, von der Maase H, Vaughn DJ, Rosenberg JE. Bellmunt J, et al. Among authors: choueiri tk. J Clin Oncol. 2010 Apr 10;28(11):1850-5. doi: 10.1200/JCO.2009.25.4599. Epub 2010 Mar 15. J Clin Oncol. 2010. PMID: 20231682 Clinical Trial.

6

Risk of arterial thromboembolic events with sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials.

Choueiri TK, Schutz FA, Je Y, Rosenberg JE, Bellmunt J. Choueiri TK, et al. J Clin Oncol. 2010 May 1;28(13):2280-5. doi: 10.1200/JCO.2009.27.2757. Epub 2010 Mar 29. J Clin Oncol. 2010. PMID: 20351323 Review.

7

Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma.

Elfiky AA, Cho DC, McDermott DF, Rosenberg JE, Fortner B, Antràs L, Chen K, Sheng Duh M, Jayawant SS, Oh WK, Atkins MB, Choueiri TK. Elfiky AA, et al. Among authors: choueiri tk. Urol Oncol. 2011 Nov-Dec;29(6):756-63. doi: 10.1016/j.urolonc.2010.01.008. Epub 2010 May 6. Urol Oncol. 2011. PMID: 20451414

8

¹¹C-methionine positron-emission tomography and computed tomography (PET-CT) in evaluating metastatic transitional cell carcinoma response to sunitinib therapy.

Katz L, Choueiri TK, Bellmunt J. Katz L, et al. Among authors: choueiri tk. BJU Int. 2010 Nov;106(9):1249-50. doi: 10.1111/j.1464-410x.2010.09732.x. BJU Int. 2010. PMID: 20963928 No abstract available.

9

Congestive heart failure risk in patients with breast cancer treated with bevacizumab.

Choueiri TK, Mayer EL, Je Y, Rosenberg JE, Nguyen PL, Azzi GR, Bellmunt J, Burstein HJ, Schutz FA. Choueiri TK, et al. J Clin Oncol. 2011 Feb 20;29(6):632-8. doi: 10.1200/JCO.2010.31.9129. Epub 2011 Jan 4. J Clin Oncol. 2011. PMID: 21205755

10

Randomized phase III trials of second-line chemotherapy in patients with advanced bladder cancer: progress and pitfalls.

Bellmunt J, Choueiri TK, Schutz FA, Rosenberg JE. Bellmunt J, et al. Among authors: choueiri tk. Ann Oncol. 2011 Feb;22(2):245-7. doi: 10.1093/annonc/mdq684. Ann Oncol. 2011. PMID: 21278220 Free article. Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

823 results

Search Page

Filters